These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 20097233

  • 1. The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.
    Sarkisyan G, Roberts AJ, Hedlund PB.
    Behav Brain Res; 2010 May 01; 209(1):99-108. PubMed ID: 20097233
    [Abstract] [Full Text] [Related]

  • 2. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.
    Bonaventure P, Kelly L, Aluisio L, Shelton J, Lord B, Galici R, Miller K, Atack J, Lovenberg TW, Dugovic C.
    J Pharmacol Exp Ther; 2007 May 01; 321(2):690-8. PubMed ID: 17314195
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The selective 5-HT(6) receptor antagonist SB-399885 enhances anti-immobility action of antidepressants in rats.
    Wesołowska A, Nikiforuk A.
    Eur J Pharmacol; 2008 Mar 17; 582(1-3):88-93. PubMed ID: 18234190
    [Abstract] [Full Text] [Related]

  • 5. Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice.
    Bourin M, Chenu F, Prica C, Hascoët M.
    Psychopharmacology (Berl); 2009 Sep 17; 206(1):97-107. PubMed ID: 19517098
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice.
    Wesołowska A, Tatarczyńska E, Nikiforuk A, Chojnacka-Wójcik E.
    Eur J Pharmacol; 2007 Jan 19; 555(1):43-7. PubMed ID: 17109856
    [Abstract] [Full Text] [Related]

  • 7. The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent.
    Pałucha-Poniewiera A, Brański P, Lenda T, Pilc A.
    J Pharmacol Exp Ther; 2010 Sep 01; 334(3):1066-74. PubMed ID: 20562216
    [Abstract] [Full Text] [Related]

  • 8. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
    Wesołowska A, Nikiforuk A.
    Neuropharmacology; 2007 Apr 01; 52(5):1274-83. PubMed ID: 17320917
    [Abstract] [Full Text] [Related]

  • 9. Delta(9)-tetrahydrocannabinol prolongs the immobility time in the mouse forced swim test: involvement of cannabinoid CB(1) receptor and serotonergic system.
    Egashira N, Matsuda T, Koushi E, Higashihara F, Mishima K, Chidori S, Hasebe N, Iwasaki K, Nishimura R, Oishi R, Fujiwara M.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):117-21. PubMed ID: 18565508
    [Abstract] [Full Text] [Related]

  • 10. Direct enhancement of hippocampal dopamine or serotonin levels as a pharmacodynamic measure of combined antidepressant-anticonvulsant action.
    Smolders I, Clinckers R, Meurs A, De Bundel D, Portelli J, Ebinger G, Michotte Y.
    Neuropharmacology; 2008 May 28; 54(6):1017-28. PubMed ID: 18378264
    [Abstract] [Full Text] [Related]

  • 11. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.
    O'Leary OF, Bechtholt AJ, Crowley JJ, Hill TE, Page ME, Lucki I.
    Psychopharmacology (Berl); 2007 Jun 28; 192(3):357-71. PubMed ID: 17318507
    [Abstract] [Full Text] [Related]

  • 12. Antidepressant-like effects in various mice strains in the tail suspension test.
    Ripoll N, David DJ, Dailly E, Hascoët M, Bourin M.
    Behav Brain Res; 2003 Aug 14; 143(2):193-200. PubMed ID: 12900045
    [Abstract] [Full Text] [Related]

  • 13. Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests.
    Takahashi E, Katayama M, Niimi K, Itakura C.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):149-56. PubMed ID: 18571641
    [Abstract] [Full Text] [Related]

  • 14. Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice.
    Mayorga AJ, Dalvi A, Page ME, Zimov-Levinson S, Hen R, Lucki I.
    J Pharmacol Exp Ther; 2001 Sep 28; 298(3):1101-7. PubMed ID: 11504807
    [Abstract] [Full Text] [Related]

  • 15. Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT₆ receptors in the dorsal raphe nucleus.
    Asaoka N, Nagayasu K, Nishitani N, Yamashiro M, Shirakawa H, Nakagawa T, Kaneko S.
    Neuropharmacology; 2015 Aug 28; 95():261-8. PubMed ID: 25863120
    [Abstract] [Full Text] [Related]

  • 16. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK, Dhir A.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):163-72. PubMed ID: 18585703
    [Abstract] [Full Text] [Related]

  • 17. Antidepressant-like effect of 17beta-estradiol: involvement of dopaminergic, serotonergic, and (or) sigma-1 receptor systems.
    Dhir A, Kulkarni SK.
    Can J Physiol Pharmacol; 2008 Oct 28; 86(10):726-35. PubMed ID: 18841177
    [Abstract] [Full Text] [Related]

  • 18. Novel antagonists of 5-HT6 and/or 5-HT7 receptors affect the brain monoamines metabolism and enhance the anti-immobility activity of different antidepressants in rats.
    Partyka A, Jastrzębska-Więsek M, Antkiewicz-Michaluk L, Michaluk J, Wąsik A, Canale V, Zajdel P, Kołaczkowski M, Wesołowska A.
    Behav Brain Res; 2019 Feb 01; 359():9-16. PubMed ID: 30312638
    [Abstract] [Full Text] [Related]

  • 19. Identification of antidepressant drug leads through the evaluation of marine natural products with neuropsychiatric pharmacophores.
    Diers JA, Ivey KD, El-Alfy A, Shaikh J, Wang J, Kochanowska AJ, Stoker JF, Hamann MT, Matsumoto RR.
    Pharmacol Biochem Behav; 2008 Mar 01; 89(1):46-53. PubMed ID: 18037479
    [Abstract] [Full Text] [Related]

  • 20. Antidepressant-like action of the ethanolic extract from Tabebuia avellanedae in mice: evidence for the involvement of the monoaminergic system.
    Freitas AE, Budni J, Lobato KR, Binfaré RW, Machado DG, Jacinto J, Veronezi PO, Pizzolatti MG, Rodrigues AL.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar 17; 34(2):335-43. PubMed ID: 20026371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.